Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
01/15/1991 | US4985458 Treatment of alzheimer*s disease |
01/15/1991 | US4985455 External preparations free of discoloration |
01/15/1991 | US4985454 Treatment of glaucoma |
01/15/1991 | US4985453 Parabanic acid derivatives and pharmaceutical compositions thereof |
01/15/1991 | US4985451 Elaiophylin derivatives, the use thereof as pharmaceuticals, and pharmaceuticals containing them |
01/15/1991 | US4985448 Ureidoindoles, pharmaceutical compositions and methods for erythrocyte and thrombocyte aggregation inhibition |
01/15/1991 | US4985447 Certain benzoquinones, naphthoquinones and derivatives thereof which exhibit thromboxane A2 synthetase inhibition or receptor antagonism and the like |
01/15/1991 | US4985446 Calcium overload blockers in brain cells |
01/15/1991 | US4985445 Cancer cell metastasis inhibitors and novel compounds |
01/15/1991 | US4985444 Pyrazolopyridine compound and processes for preparation thereof |
01/15/1991 | US4985443 Method and composition for treating vitiligo |
01/15/1991 | US4985442 2-substituted-1-naphthols as 5-lipoxygenase inhibitors |
01/15/1991 | US4985441 Anti-tumor agents |
01/15/1991 | US4985440 Hypolipidaemic imidazol-2-yl-derivatives of bicyclic compounds |
01/15/1991 | US4985437 Medicaments |
01/15/1991 | US4985436 Composition of matter for inhibiting leukemias and sarcomas |
01/15/1991 | US4985435 2-substituted-1-naphthols as 5-lipoxygenase inhibitors |
01/15/1991 | US4985431 Producing tetramethyl pyrazine from a plant extract |
01/15/1991 | US4985428 Isoxazoles with nootropic activity |
01/15/1991 | US4985427 Triazine derivatives |
01/15/1991 | US4985425 Dissolved composition of [benzo-1,2,4-thiadiazine]-1,1-dioxide |
01/15/1991 | US4985424 Certain substituted 1,7-annelated 1h-indazoles being selective antagonists of 5-ht-receptors |
01/15/1991 | US4985423 New 1,4-diazepine derivatives having anit-ulcer activity |
01/15/1991 | US4985422 Tricyclic, imidazole substituted, antagonist of hydroxytryptamine receptors, psychotic disorders, schizophrenia |
01/15/1991 | US4985420 1,7-annelated indolecarboxylic acid esters and -amides |
01/15/1991 | US4985419 Phenothiazine derivatives, their preparation and pharmaceutical compositions containing them |
01/15/1991 | US4985418 Steroid for treating bowel disease |
01/15/1991 | US4985417 Treatment of glaucoma |
01/15/1991 | US4985416 Platinum complexes of azodiazonium dyes as anti-tumor agents |
01/15/1991 | US4985410 Quaternary ammonium salts of polysaccharides, prossessing hypocholesterolemic activity |
01/15/1991 | US4985409 Adenosine derivatives and pharmaceutical composition thereof |
01/15/1991 | US4985408 Producing puerarin from plant roots |
01/15/1991 | US4985405 Therapeutic product based on organic silicon derivatives |
01/15/1991 | US4985248 Oleanolic acid, saponins of litchi, kuguasu |
01/15/1991 | US4985247 Pharmaceutical composition for inhibiting viruses and increasing immune function (PII) |
01/15/1991 | US4985235 Treatment of periodontoclasia with retinoic acid |
01/15/1991 | US4985063 Insecticides, miticides, herbicides |
01/15/1991 | CA2036386A1 9-fluoroprostaglandin derivatives, process for their production and their pharmaceutical use |
01/15/1991 | CA2036383A1 8-and 9-prostaglandin derivatives, process for their production and their pharmaceutical use |
01/15/1991 | CA2021145A1 Acrylic amide derivatives, a process for their preparation, pharmaceutical compositions containing the same and their use in medicine |
01/15/1991 | CA2021142A1 Use in therapy of 10-amino-5,6-dihydro-11h-dibenzo(b,e)azepine-6,11-dione and derivatives as drugs for use in the treatment of urinary incontinence |
01/15/1991 | CA2021136A1 Acrylic acid salts, a process for their preparation, pharmaceutical compositions containing them and their use in the medicine |
01/15/1991 | CA2021051A1 Pharmaceutical compositions containing acrylic acid derivatives and their use in the medicine |
01/15/1991 | CA2021049A1 Substituted benzonitriles |
01/15/1991 | CA2021006A1 Base modified nucleosides |
01/15/1991 | CA1279067C Benzoic acid derivatives, as well as processes for their production and their use as pharmaceuticals |
01/15/1991 | CA1279064C 1-pyrimidinyloxy-3-hetarylalkylamino-2-propanols, preparation, and uses |
01/15/1991 | CA1279063C N-6 substituted adenosine derivatives as cardiac vasodilators |
01/15/1991 | CA1279015C Increasing aqueous humor outflow |
01/15/1991 | CA1279014C Granules of thiamine salt and the production thereof |
01/15/1991 | CA1279013C Antibiotic composition for the treatment of arthritis |
01/15/1991 | CA1279011C Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport |
01/14/1991 | WO1991001123A2 Quinolinyl-benzopyran derivatives as antagonists of leukotriene d¿4? |
01/14/1991 | WO1991000856A2 (1,2n) and (3,2n)-carbocyclic-2-amino tetralin derivatives |
01/14/1991 | WO1991000854A1 N,n'-dicarboxymethyl, n,n'-diaminocarbonylmethyl-diaminoalkane derivatives and their use in pharmaceutical compositions |
01/14/1991 | WO1991000729A2 Bis-dioxopiperazines, and their use as protecting agents |
01/14/1991 | CA2036381A1 Quinolinyl-benzopyran derivatives as antagonists of leukotriene d4 |
01/14/1991 | CA2033203A1 Pharmaceutical compositions |
01/14/1991 | CA2033192A1 Pharmaceutical compositions |
01/14/1991 | CA2021135A1 Pyrrolo[2,1-b]thiazole derivatives |
01/14/1991 | CA2021056A1 Anti-infective agents, process for their preparation and their use in therapy |
01/14/1991 | CA2021032A1 Alkylimino-2-benzothiazoline derivatives, process for their preparation and medicaments containing same |
01/14/1991 | CA2021031A1 Imino-2(heterocyclylalkyl)-3-benzothiazoline derivatives, process for their preparation and medicaments containing same |
01/14/1991 | CA2021025A1 3-substituted vinyl cephalosporin derivatives |
01/14/1991 | CA2020936A1 Indole derivatives |
01/13/1991 | WO1991000862A1 Substituted 2-imidazolines and preparation and use thereof |
01/13/1991 | CA2064095A1 Substituted 2-imidazolines and preparation and use therof |
01/13/1991 | CA2020986A1 Halogenated pyrimidine 3-oxide derivatives, their use for the treatment and prevention of hair loss and for stimulating its regrowth |
01/13/1991 | CA2020966A1 Polymeric salt delivery systems |
01/13/1991 | CA2020964A1 Pharmaceutical active derivative delivery systems |
01/13/1991 | CA2020963A1 Delivery systems for quaternary and related compounds |
01/13/1991 | CA2020891A1 Antiseptic compositions containing hexahydro-5-pyrimidinamine compounds and an amphoteric surfactant and methods for preparing same |
01/13/1991 | CA2020806A1 Thienodiazepine derivatives |
01/13/1991 | CA2020802A1 Solid dosage form for pharmaceutically active drugs |
01/12/1991 | CA2020805A1 Heterocyclic compounds containing nitrogen and sulfur, pharmaceutical compositions containing them and process for preparing same |
01/12/1991 | CA2020794A1 Galactanne extracted from klebsiella, process for its obtention and use as medicament |
01/11/1991 | CA2020769A1 5,6-dihydro[1h-indolo[3,2-c]quinoline-6,4-piperidines] and related compounds, a process for their preparation and their use as medicaments |
01/11/1991 | CA2020261A1 Polyprenyl compound composition for soft capsules |
01/10/1991 | WO1991000348A1 Modified vp1/p2a regions of the rhinoviral system |
01/10/1991 | WO1991000289A2 Targeted liposomes and methods for liposome-protein coupling |
01/10/1991 | WO1991000282A1 Therapeutic nucleosides |
01/10/1991 | WO1991000274A1 N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
01/10/1991 | WO1991000271A1 Novel vitamin d analogues |
01/10/1991 | WO1991000259A1 D-propranolol as a selective adenosine antagonist |
01/10/1991 | WO1991000110A1 Fluorocarbon emulsions having saturated phospholipid emulsifiers |
01/10/1991 | WO1991000101A1 Use of peroxidated lipids for the preparation of medication to be used in the treatment, by local application, of circulation deficiencies |
01/10/1991 | WO1991000096A1 Low-dosage sublingual aspirin |
01/10/1991 | WO1991000094A1 A new papaverine injection system |
01/10/1991 | WO1991000093A1 Bis-acyloxymethyl derivatives |
01/10/1991 | WO1991000091A1 Use of norverapamil and norgallopamil as anti-arteriosclerosis drugs |
01/10/1991 | WO1991000090A1 Oxygenation of blood substitutes |
01/10/1991 | WO1991000089A1 Medicaments for human beings and animals and other uses of different acids and salts |
01/10/1991 | WO1991000087A1 Skin moisturizing/conditioning antimicrobial alcoholic gels |
01/10/1991 | WO1991000082A1 Antimicrobial polymeric bisbiguanides |
01/10/1991 | WO1991000081A2 Anti-malarial composition and method of use |
01/10/1991 | WO1990012560A3 Preparation for care of nails, skin and hair |
01/10/1991 | WO1990012117A3 Sugar composition comprising soluble fibre |
01/10/1991 | DE3920369A1 Pharmaceutical for preventing and treating migraine - contains 1-(P-2-isopropoxy:ethoxy:methyl-phenoxy)-3-isopropyl amino-propanol |
01/09/1991 | EP0407345A2 Topical formulations |
01/09/1991 | EP0407344A2 Pharmaceutical preparation for topical application |